183
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

, , , , , , , & show all
Pages 936-939 | Received 23 Apr 2013, Accepted 20 Jun 2013, Published online: 30 Jul 2013

References

  • Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metabol 2004;89:2745–9
  • Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1357–63
  • Xiang SK, Hua F, Tang Y, et al. Relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome. Int J Endocrinol 2012;2012:173281
  • Jacobi D, Stanya KJ, Lee CH. Adipose tissue signaling by nuclear receptors in metabolic complications of obesity. Adipocyte 2012;1:4–12
  • Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril 2011;95:1048–58
  • Mannerås-Holm L, Baghaei F, Holm G, et al. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011;96:1068–76
  • Thomson RL, Spedding S, Buckley JD. Vitamin D in the etiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012;77:343–50
  • Seow KM, Juan CC, Wang PH, et al. Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome. Gynecol Obstet Invest 2012;73:236–41
  • The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks to polycystic ovary syndrome. Hum Reprod 2004;19:41–7
  • World Health Organization – http://apps.who.int/bmi/index.jsp
  • Grundy SM, Chair M, Cleeman JI, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:285–90
  • Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promotor polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995;74:1032–4
  • Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation 2003;107:499–511
  • Sposito AC, Caramelli B, Fonseca FAH, et al. IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2007;88:1–18
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30
  • Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009;1:1–6
  • American Diabetes Association (ADA). Clinical practice recommendations. Diabetes Care 2013;36:S1–S2
  • Qu HQ, Li Q, Rentfro AR, et al. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One 2011;6:e21041
  • National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1333–445
  • Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 2012;33:812–41
  • Oh JY, Sung YA, Lee HJ, et al. Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome. Obesity 2010;18:593–97
  • Wongwananuruk T, Rattanachaiyanont M, Indhavivadhana S, et al. Prevalence and clinical predictors of insulin resistance in reproductive-aged Thai women with polycystic ovary syndrome. Int J Endocrinol 2012;2012:529184
  • Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005;26:19–39
  • Lazar MA. How obesity causes diabetes: not a tall tale. Science 2005;307:373–5
  • Pontes AG, Rehme MF, Martins AM, et al. Insulin resistance in women with polycystic ovary syndrome: relationship with anthropometric and biochemical variables. Rev Bras Ginecol Obstet 2012;34:74–9
  • Loskutoff DJ, Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 1998;18:1–6
  • Fernandes KS, Sandrim VC. 4G/5G polymorphism modulates PAI-1 circulating levels in obese women. Mol Cell Biochem 2012;364:299–301
  • Al-Hamodi ZH, Saif-Ali R, Ismail IS, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. J Clin Biochem Nutr 2012;50:184–9
  • Kudo K, Hasegawa S, Suzuki Y, et al. 1α, 25-Dihydroxyvitamin D3 inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells. J Steroid Biochem Mol Biol 2012;132:290–4
  • Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal 2011;15:607–38

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.